Your Health. Your Family. Your Choice.
Life Threatening? No
Write-up: death; intramuscular at 0.3 mL, single in the right thigh; This is a spontaneous report from a contactable consumer downloaded from the regulatory authority-WEB, regulatory authority number HU-OGYI-096021. An 83-year-old female patient received the second dose of bnt162b2 (COMIRNATY) (Lot # EJ6790), intramuscular at 0.3 mL, single in the right thigh on 17Feb2021 for COVID-19 immunisation. Medical history included atrial fibrillation and flutter, dementia, hypertension, and bilateral femoral neck fracture in 2014 and in 2017. Concomitant medication included enoxaparin sodium (CLEXANE), tiapride hydrochloride (TIAPRIDAL), vinpocetine (CAVINTON FORTE), alprazolam (FRONTIN), perindopril arginine (COVEREX AS). Previously the patient received the first dose of Comirnaty (Lot # EJ6134) intramuscular in the left arm on 27Jan2021 for COVID-19 immunisation. The patient experienced death on 20Feb2021. The patient died on 20Feb2021. It was not reported if an autopsy was performed. Sender Comment: The 83 year-old patient died 3 days after Comirnaty vaccination. There is no information about the cause of death or whether autopsy was done. The causal relationship between the reported death and Comirnaty was unassessable. The case is serious due to fatal outcome. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: death
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166